The price of Armodafinil 150 mg can vary based on several factors, including the pharmacy, location, insurance coverage, and whether a generic version is available.
How much does Armodafinil 150 mg typically cost?
Without insurance, a 30-day supply of brand-name Armodafinil 150 mg (Nuvigil) can range from $300 to $500 or more [1]. The cost for Armodafinil 150 mg generics can be significantly lower, often falling between $50 and $100 for a 30-day supply, depending on the manufacturer and pharmacy [1]. Prices can fluctuate and are subject to change.
What influences the price of Armodafinil?
The primary factor influencing price is the availability of generic versions. Once patents expire, other manufacturers can produce generic versions, which typically drives down the cost. Insurance plans also play a significant role, with copay amounts varying widely [1]. The specific pharmacy where the prescription is filled can also lead to price differences.
When will Armodafinil patents expire?
Armodafinil is the R-enantiomer of modafinil. Patents related to Armodafinil and its uses have been the subject of legal challenges and variations in expiry dates. Information on specific patent expiry dates for Armodafinil can be found on resources like DrugPatentWatch.com [2].
Are there lower-cost alternatives to Armodafinil?
Yes, generic versions of Armodafinil are available, offering a less expensive option compared to the brand-name drug [1]. Modafinil, the racemic mixture from which Armodafinil is derived, is another related medication that may have different pricing structures.
How can I find the cheapest Armodafinil 150 mg?
To find the most affordable Armodafinil 150 mg, it is advisable to compare prices at different pharmacies. Using prescription discount cards or coupons can also reduce out-of-pocket costs. Checking with your insurance provider about coverage and copayments for both brand-name and generic Armodafinil is also a crucial step [1].
Sources:
[1] GoodRx. "Armodafinil Prices, Coupons, and Patient Assistance Programs." Accessed October 26, 2023.
[2] DrugPatentWatch.com. Accessed October 26, 2023.